atai Life Sciences N.V., (NASDAQ: ATAI), a clinical stage biopharmaceutical company aiming to transform the treatment of mental health disorders, announced today its appointment of Dr. Kirpekar to serve as the Company’s Chief Business Officer, effective today. In this newly created role, Dr. Kirpekar will be responsible for atai’s pipeline strategy, building out its commercial…